[go: up one dir, main page]

FR2595714B1 - Procede perfectionne de production d'interleukine-0 - Google Patents

Procede perfectionne de production d'interleukine-0

Info

Publication number
FR2595714B1
FR2595714B1 FR878702010A FR8702010A FR2595714B1 FR 2595714 B1 FR2595714 B1 FR 2595714B1 FR 878702010 A FR878702010 A FR 878702010A FR 8702010 A FR8702010 A FR 8702010A FR 2595714 B1 FR2595714 B1 FR 2595714B1
Authority
FR
France
Prior art keywords
improved process
producing interleukin
interleukin
producing
improved
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Fee Related
Application number
FR878702010A
Other languages
English (en)
Other versions
FR2595714A1 (fr
Inventor
Alvin Seth Stern
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
F Hoffmann La Roche AG
Original Assignee
F Hoffmann La Roche AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by F Hoffmann La Roche AG filed Critical F Hoffmann La Roche AG
Publication of FR2595714A1 publication Critical patent/FR2595714A1/fr
Application granted granted Critical
Publication of FR2595714B1 publication Critical patent/FR2595714B1/fr
Anticipated expiration legal-status Critical
Expired - Fee Related legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/545—IL-1
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/14—Lymphokine; related peptides
    • Y10S930/141—Interleukin

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Genetics & Genomics (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Zoology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
FR878702010A 1986-02-18 1987-02-12 Procede perfectionne de production d'interleukine-0 Expired - Fee Related FR2595714B1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/830,406 US5831022A (en) 1986-02-18 1986-02-18 Purification of recombinant human IL-1α

Publications (2)

Publication Number Publication Date
FR2595714A1 FR2595714A1 (fr) 1987-09-18
FR2595714B1 true FR2595714B1 (fr) 1990-05-18

Family

ID=25256938

Family Applications (1)

Application Number Title Priority Date Filing Date
FR878702010A Expired - Fee Related FR2595714B1 (fr) 1986-02-18 1987-02-12 Procede perfectionne de production d'interleukine-0

Country Status (10)

Country Link
US (1) US5831022A (fr)
JP (1) JP2590085B2 (fr)
BE (1) BE1000636A5 (fr)
CH (1) CH676008A5 (fr)
DE (1) DE3704868C2 (fr)
DK (1) DK171419B1 (fr)
FR (1) FR2595714B1 (fr)
GB (1) GB2186580B (fr)
IT (1) IT1202565B (fr)
NL (1) NL8700397A (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
ATE92766T1 (de) * 1987-12-18 1993-08-15 Immunex Corp Oertliche wundheilmittel, die interleukin-1proteine enthalten.
EP0644203A1 (fr) * 1988-07-29 1995-03-22 Otsuka Pharmaceutical Co., Ltd. Dérivés de l'il-1 alpha et médicament contre la thrombocytopénie
IT1226713B (it) * 1988-08-05 1991-02-05 Eniricerche Spa Procedimento per la preparazione di interleuchina 1 beta umana ricombinante in forma omogenea.
NZ295998A (en) * 1994-10-24 1999-10-28 Ophidian Pharm Inc Neutralizing antitoxins against clostridium difficile and clostidium botulinum toxins

Family Cites Families (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4401756A (en) * 1981-04-14 1983-08-30 Immunex Corporation Process for preparing human interleukin 2
CA1341562C (fr) * 1982-03-31 2007-11-27 Tadatsugu Taniguchi Gene codant pour un polypeptide ayant une activite interleukine 2, adn recombinant portant ledit gene, lignees cellulaires possedant ledit adn recombinant et procede pour la preparation d'interleukine 2 en utilisant lesdites cellules
GR79124B (fr) * 1982-12-22 1984-10-02 Genentech Inc
FR2550802B1 (fr) * 1983-08-17 1986-04-11 Inst Nat Sante Rech Med Procede de production d'interleukine 1 humaine et medicaments correspondants
CA1340853C (fr) * 1983-12-23 1999-12-21 Hsiang-Fu Kung Purification d'une interleukine-2 recombinante
JPS60149386A (ja) * 1984-01-17 1985-08-06 Dainippon Pharmaceut Co Ltd インタ−ロイキン１をコ−ドする伝令リボ核酸及びその調製法
JPS60197629A (ja) * 1984-03-16 1985-10-07 Chemo Sero Therapeut Res Inst ＨＢｓ抗原の精製方法
DE3419995A1 (de) * 1984-05-29 1985-12-05 Hoechst Ag, 6230 Frankfurt Gentechnologisches verfahren zur herstellung von human-interleukin-2 und mittel zur durchfuehrung dieses verfahrens
JPS617296A (ja) * 1984-06-19 1986-01-13 イミユネツクス、コ−ポレ−シヨン インタ−ロイキン１の遺伝子の精製、クロ−ニング及び特性づけ
CA1341433C (fr) * 1984-06-19 2003-06-24 Douglas P. Cerretti Purification de l'interleukine 1
DE3432196A1 (de) * 1984-09-01 1986-03-06 Boehringer Ingelheim International GmbH, 6507 Ingelheim Neues mechanisches aufschlussverfahren von bakterienzellen zur isolierung von rekombinant hergestellten peptiden
DE3683186D1 (de) * 1985-04-25 1992-02-13 Hoffmann La Roche Rekombinantes humaninterleukin-1.
US4675387A (en) * 1985-07-26 1987-06-23 E. I. Du Pont De Nemours And Company Method for extracting protein with organic acid
US5008374A (en) * 1986-03-14 1991-04-16 Otsuka Pharmaceutical Co., Ltd. IL-1α derivatives and drugs
US4801686A (en) * 1986-09-04 1989-01-31 Immunex Corporation Purification of recombinant interleukin-1

Also Published As

Publication number Publication date
IT1202565B (it) 1989-02-09
DK77387D0 (da) 1987-02-16
IT8719420A0 (it) 1987-02-18
BE1000636A5 (fr) 1989-02-28
US5831022A (en) 1998-11-03
GB2186580B (en) 1990-08-22
JP2590085B2 (ja) 1997-03-12
GB8703663D0 (en) 1987-03-25
DE3704868C2 (de) 1995-09-21
FR2595714A1 (fr) 1987-09-18
JPS62209097A (ja) 1987-09-14
DK171419B1 (da) 1996-10-21
DK77387A (da) 1987-08-19
CH676008A5 (fr) 1990-11-30
DE3704868A1 (de) 1987-08-20
NL8700397A (nl) 1987-09-16
GB2186580A (en) 1987-08-19

Similar Documents

Publication Publication Date Title
FR2582294B1 (fr) Procede de production d'alumine-beta
FR2634194B1 (fr) Procede de production d'alumines boehmitiques
FR2565229B1 (fr) Procede de production d'epichlorhydrine
FR2624865B1 (fr) Procede de production de polybutenes
FR2593513B1 (fr) Procede de production d'essence
MA21610A1 (fr) Procede de production de composes triazoliques .
FR2531440B1 (fr) Procede de production d'une membrane microporeuse
BE878902A (fr) Procede de production d'alkylene-glycols
FR2558156B1 (fr) Procede de produ
FR2555603B1 (fr) Procede de production d'enzymes cellulolytiques
FR2573431B1 (fr) Procede de production d'un polymere
FR2593175B1 (fr) Procede de production de 3-phenyl-4-cyanopyrroles.
FR2561238B1 (fr) Procede de production de diphenylamines ou de n,n'-diphenyl-phenylenediamines
FR2490975B1 (fr) Procede de production d'objets en forme
FR2514758B1 (fr) Procede de production d'uree
FR2559490B1 (fr) Procede de production d'oligoglucosylfructosides tres purs
MA22151A1 (fr) Procede de production d'azabenzimidazoles
FR2573771B1 (fr) Procede de production de peroxydase
FR2567522B1 (fr) Procede de fabrication de dianydride de silylnorbornane
HUT48571A (en) Process for production of substituated 3,5-dichlor-2,4-difluor-benzol
FR2663941B1 (fr) Procede de production d'organosiloxanes.
FR2595714B1 (fr) Procede perfectionne de production d'interleukine-0
FR2539757B1 (fr) Procede de production de bilirubine-oxydase
FR2623511B1 (fr) Procede de production de polymeres d'organophosphazene
FR2625194B1 (fr) Procede de production d'aldehydes aromatiques

Legal Events

Date Code Title Description
TP Transmission of property
ST Notification of lapse